Presentation is loading. Please wait.

Presentation is loading. Please wait.

Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature.

Similar presentations


Presentation on theme: "Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature."— Presentation transcript:

1 Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature Case Rep Oncol 2015;8: DOI: / Fig. 1. Cytomorphology of a bone marrow aspirate smear (×63) performed in August 2010 showing high-grade diffuse infiltration with atypical plasma cells. © 2015 S. Karger AG, Basel - CC BY-NC 3.0

2 Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature Case Rep Oncol 2015;8: DOI: / Fig. 2. Disease course based on M protein levels indicated in months after primary diagnosis (DX).Benda = Bendamustine; Len = lenalidomide; Dex = dexamethasone; Bort = bortezomib; Cyclo = cyclophosphamide; Mel = melphalan; Poma = pomalidomide; VCD = bortezomib/cyclophosphamide/dexamethasone. © 2015 S. Karger AG, Basel - CC BY-NC 3.0

3 Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature Case Rep Oncol 2015;8: DOI: / Fig. 3. Radiograph of a pathological humeral fracture corresponding to serological disease progression in June Imaging after osteosynthesis with a proximally and distally fixed intramedullary nail. © 2015 S. Karger AG, Basel - CC BY-NC 3.0


Download ppt "Long-Term Disease Control by Pomalidomide-/Dexamethasone-Based Therapy in a Patient with Advanced Multiple Myeloma: A Case Report and Review of the Literature."

Similar presentations


Ads by Google